Age and sharing of needle injection equipment in a cohort of Massachusetts injection drug users: An observational study

Addiction Science and Clinical Practice

Volumn 8, Issue 1, 2013, Pages

  Tassiopoulos, Katherine ^a   Bernstein, Judith ^b   Bernstein, Edward ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

Hepatitis C; Injection drug use; Injection equipment sharing; Young age

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; DRUG ABUSE; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; PREVALENCE; PSYCHOLOGICAL ASPECT; SOCIOECONOMICS; STATISTICS; SUBSTANCE ABUSE; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; NEEDLE SHARING; PREVALENCE; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84907018787     PISSN: 19400632     EISSN: 19400640     Source Type: Journal    
DOI: 10.1186/1940-0640-8-20     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention (CDC): Hepatitis C virus infection among adolescents and young adults - Massachusetts, 2002-2009. MMWR Morb Mortal Wkly Rep. 2011, 60: 537-541.
2. National Drug Intelligence Center, US Department of Justice: National Drug Threat Assessment 2010. 2010, [ http://www.justice.gov/archive/ndic/pubs38/38661/ ]
3. Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER: Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001, 91: 42-46.
4. Latkin C, Buchanan A, Metsch L, Knight K, Latka M, Mizuno Y, Knowlton A, for the Intervention for Seropositive Injectors-Research Evaluation Team: Predictors of sharing injection equipment by HIV-seropositive injection drug users. J Acquir Immune Defic Syndr. 2008, 49: 447-450. 10.1097/QAI.0b013e31818a6546.
5. Stein M, Solomon D, Herman D, Anderson B, Miller I: Depression severity and drug injection HIV risk behaviors. Am J Psychiatry. 2003, 160: 1659-1662. 10.1176/appi.ajp.160.9.1659.
6. Delgado M, Lundgren L, Deshpande A, Lonsdale J, Purington T: The association between acculturation and needle sharing among Puerto Rican injection drug users. Eval Program Plann. 2008, 31: 83-91. 10.1016/j.evalprogplan.2007.05.010.
7. Booth R, Kwiatkowski C, Mikulich-Gilbertson S, Brewster J, Salomonsen-Sautel S, Corski K, Sinitsyna L: Predictors of risky needle use following interventions with injection drug users in Ukraine. Drug Alcohol Depend. 2006, 82 (Suppl 1): 49-55.
8. Buxton M, Vlahov D, Strathdee C, Des Jarlais D, Morse E, Ouellet L, Kerndt P, Garfein R: Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend. 2004, 75: 177-10.1016/j.drugalcdep.2004.01.014.
9. De P, Cox J, Boivin J, Platt R, Jolly A, Alexander P: HIV and HCV discordant injecting partners and their association to drug equipment sharing. Scand J Infect Dis. 2009, 41: 206-214. 10.1080/00365540902721376.
10. Mandell W, Vlahov D, Latkin C, Oziemkowska M, Cohn S: Correlates of needle sharing among injection drug users. Am J Public Health. 1994, 84: 920-923. 10.2105/AJPH.84.6.920.
11. Metsch L, Pereyra M, Purcell D, Latkin C, Malow R, Gomez C, Latka M, for the INSPIRE Study Team: Correlates of lending needles/syringes among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr. 2007, 46 (Suppl 2): 72-79.
12. Seal K, Edlin B, Ochoa K, Tulsky J, Moss A, Hahn J: Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention. West J Med. 2000, 172: 16-20. 10.1136/ewjm.172.1.16.
13. Watters J, Estilo M, Clark G, Lorvick J: Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA. 1994, 271: 115-120. 10.1001/jama.1994.03510260047027.
14. Doherty M, Garfein R, Monterosso E, Brown D, Vlahov D: Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000, 14: 717-726. 10.1097/00002030-200004140-00011.
15. Garfein R, Doherty M, Monterroso E, Thomas D, Nelson K, Vlahov D: Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 18 (Suppl 1): 11-199.
16. Miller CL, Johnston C, Spittal PM, Li K, LaLiberte N, Montaner J, Schechter M: Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatol. 2002, 36: 737-742. 10.1053/jhep.2002.35065.
17. Bernstein E, Bernstein J, Levenson S: Project ASSERT: an ED based intervention to increase access to primary care, preventive services, and the substance abuse treatment system. Ann Emerg Med. 1997, 30: 181-189. 10.1016/S0196-0644(97)70140-9.
18. Skinner HA: The Drug Abuse Screening Test (DAST-10): Guidelines for administration and scoring. 1995, Toronto: Addiction Research Foundation
19. Bernstein E, Ashong D, Heeren T, Winter M, Bliss C, Madico G, Bernstein J: The impact of a brief motivational intervention on unprotected sex and sex while high among drug-positive emergency department patients who receive STI/HIV VC/T and drug treatment referral as standard of care. AIDS Behav. 2012, 16: 1203-1216. 10.1007/s10461-012-0134-0.
20. Ruggiero KJ, DelBen K, Scotti JR, Rabalais AF: Psychometric properties of the PTSD checklist-civilian version. J Trauma Stress. 2003, 16: 495-502. 10.1023/A:1025714729117.
21. Lankenau S, Teti M, Silva K, Bloom J, Harocopos A, Treese M: Initiation into prescription opioid misuse among young injection drug users. Int J Drug Policy. 2012, 23: 37-44. 10.1016/j.drugpo.2011.05.014.
22. Page K, Morris M, Hahn J, Maher L, Prins M: Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis. 2013, 57 (Suppl 2): 32-38. 10.1093/cid/cit300.
23. Peters A, Davies T, Richardson A: Multi-site samples of injecting drug users in Edinburgh: prevalence and correlates of risky injecting practices. Addiction. 1998, 93: 253-267. 10.1046/j.1360-0443.1998.9322539.x.
24. Costenbader EC, Astone NM, Latkin CA: The dynamics of injection drug users' personal networks and HIV risk behaviors. Addiction. 2006, 101: 1003-1013. 10.1111/j.1360-0443.2006.01431.x.
25. Hoffmann JP, Su SS, Pach A: Changes in network characteristics and HIV risk behavior among injection drug users. Drug Alcohol Depend. 1997, 46: 41-51. 10.1016/S0376-8716(97)00038-0.
26. Zerden L, López LM, Lundgren L: Needle sharing among Puerto Rican injection drug users in Puerto Rico and Massachusetts: place of birth and residence matter. Subst Use Misuse. 2010, 45: 1605-1622. 10.3109/10826081003682842.
27. Centers for Disease Control and Prevention (CDC): HIV-associated behaviors among injecting-drug users - 23 cities, United States, May 2005-February 2006. MMWR Morb Mortal Wkly Rep. 2009, 58: 329-332.
28. Des Jarlais D, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, Rockwell R, Edwards V, Friedman S, Monterroso E, Williams I, Garfein R: Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol. 2003, 157: 467-471. 10.1093/aje/kwf222.
29. Thorpe L, Ouellet L, Hershow R, Bailey S, Williams I, Williamson J, Monterroso E, Garfein R: Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002, 155: 645-653. 10.1093/aje/155.7.645.